Search results for: 'research area cell cycle rad51'
- A9934 Zymosan ASummary: A polysaccharide compound extracted from the cell wall of yeast
- F1839 Anti-NCAM1/CD56 Antibody (Lorvotuzumab-MMAE)Summary: Anti-NCAM1/CD56 Antibody (Lorvotuzumab-MMAE)
- F1062 Anti-PSGL1/CD162 Antibody (Neihulizumab)Summary: Anti-PSGL1/CD162 Antibody (Neihulizumab)
- K4411 Concanavalin A (Con A) Solution (500X)Summary: Concanavalin A (Con A) is a potent leukocyte mitogen, which can be used for in vitro activation of human and mouse leukocytes.
- BA9734 MC-1-F2Summary: MC-1-F2 is an inhibitor that reduces epithelial-mesenchymal transition (EMT) labeling, inhibits cancer stem cell (CSC) properties, and decreases invasiveness of denuded resistant prostate cancer (CRPC) cell lines in breast cancer cell lines.
- BA9040 GamabufotalinSummary: Gamabufotalin (Gamabufagin), the main toadstoolene in toadstools, is widely used in cancer research due to its stability and low toxicity.
- F1559 Anti-Mesothelin Antibody (Anetumab-MMAE)Summary: Anti-Mesothelin Antibody (Anetumab-MMAE)
- F1854 Anti-Siglec-2/CD22 Antibody (Inotuzumab-CLM)Summary: Anti-Siglec-2/CD22 Antibody (Inotuzumab-CLM)
- F1465 Anti-Siglec-2/CD22 Antibody (Inotuzumab-MMAE)Summary: Anti-Siglec-2/CD22 Antibody (Inotuzumab-MMAE)
- F1924 Anti-AXL/UFO Antibody (Tilvestamab-MMAE)Summary: Anti-AXL/UFO Antibody (Tilvestamab-MMAE)